New anti-Entamoeba histolytica multistage drugs are needed because only one drug class, nitroimidazoles, is available for treating invasive disease, and it does not effectively eradicate the infective cyst stage. Zinc ditiocarb (ZnDTC), a main metabolite of the FDA-approved drug disulfiram, was recently shown to be highly effective against the invasive trophozoite stage. In this brief report, we show that ZnDTC is active against cysts, with similar potency to first-line cysticidal drug paromomycin.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664845 | PMC |
| http://dx.doi.org/10.1128/aac.00832-22 | DOI Listing |
Publication Analysis
Top Keywords
drug disulfiram
8
alcohol abuse
4
drug
4
abuse drug
4
disulfiram effective
4
effective cyst
4
cyst stages
4
stages entamoeba
4
entamoeba histolytica
4
histolytica parasite
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!